(ANSA) - BRUSSELS, MARCH 24 - The European Commission has adopted a revision of the mechanism for authorizing the export of vaccines, adding "reciprocity" and "proportionality" among the criteria to be evaluated for the green light.
Applications will be assessed on a case-by-case basis, but the aim is that export requests do not pose a threat to the security of serum supply for the 27 EU countries. The initiative revokes the exemption for 17 countries, while Covax's 92 low- and middle-income countries remain excluded from the instrument's scope. In addition, Commission President Urusula von der Leyen announced that "we are allowing EMA to approve updated vaccines faster to address new variants. Faster approval means more vaccines in circulation and more Europeans protected from the virus." (HANDLE).
